Department of Public Health and Pediatrics, University of Turin, Turin, Italy.
Department of Public Health and Pediatrics, University of Turin, Turin, Italy.
J Infect Public Health. 2024 Jul;17(7):102457. doi: 10.1016/j.jiph.2024.05.045. Epub 2024 May 24.
Antimicrobial stewardship (AMS) programs have been differently implemented across Europe. This study primarily aimed to compare AMS in two European regions. Secondarily, the study explored the COVID-19 pandemic impact on surrogate outcome indicators of AMS.
A retrospective observational study was conducted in Piedmont (Italy) and Catalonia (Spain). AMS programs were compared through structure and process indicators in 2021. Changes in surrogate outcome indicators (antimicrobial usage; alcohol-based sanitizer consumption; antimicrobial resistance, AMR) from 2017 to 2021 described the pandemic impact.
Seventy-eight facilities provided structure and process indicators. Catalonia showed better structure scores (p < 0.001) and less dispersion in both indicators. The greatest areas to improve were accountability (Piedmont) and diversification of strategies (Catalonia). Overall, the regions reported consistent changes in outcome indicators. Antimicrobial usage decreased in 2020, returning to near-pre-pandemic levels in 2021. Alcohol-based sanitizer consumption surged in 2020, then dipped remaining above pre-pandemic levels. AMR trends were minimally affected.
The centralized approach of Catalonia ensured consistent attainment of quality objectives across all facilities, but it may limit facility-specific strategies. In Piedmont, accountability remain one of the most critical factors as in previous years. The pandemic did not substantially disrupt surrogate outcome measures of AMS. However, the data on AMR suggest that maintaining vigilance against this issue remains paramount.
抗菌药物管理(AMS)计划在欧洲各地的实施方式存在差异。本研究主要旨在比较两个欧洲地区的 AMS。其次,研究探索了 COVID-19 大流行对 AMS 的替代结果指标的影响。
在意大利皮埃蒙特和西班牙加泰罗尼亚进行了一项回顾性观察研究。2021 年通过结构和过程指标比较了 AMS 计划。描述大流行影响的是替代结果指标(抗菌药物使用量;酒精基消毒剂消耗;抗菌药物耐药性,AMR)的变化。
78 家机构提供了结构和过程指标。加泰罗尼亚的结构得分更好(p<0.001),且两个指标的分散度更小。需要改进的最大领域是问责制(皮埃蒙特)和策略多样化(加泰罗尼亚)。总体而言,两个地区报告的结果指标变化一致。2020 年抗菌药物使用量下降,2021 年恢复到接近大流行前的水平。2020 年酒精基消毒剂消耗猛增,随后略有下降,但仍高于大流行前的水平。AMR 趋势受影响较小。
加泰罗尼亚的集中方法确保了所有机构都能一致实现质量目标,但这可能限制了机构特定的策略。在皮埃蒙特,与前几年一样,问责制仍然是最关键的因素之一。大流行并没有严重打乱 AMS 的替代结果指标。然而,关于 AMR 的数据表明,对这个问题保持警惕仍然至关重要。